{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:46:56Z","timestamp":1793191616471,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001367"],"award-info":[{"award-number":["82001367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0180"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0180"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.seizure.2024.02.004","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:21:47Z","timestamp":1707279707000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network meta-analysis"],"prefix":"10.1016","volume":"117","author":[{"given":"Dujiang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-3729","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-7418","authenticated-orcid":false,"given":"Yankun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-7843","authenticated-orcid":false,"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.seizure.2024.02.004_bib0001","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.seizure.2024.02.004_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2024.02.004_bib0003","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","article-title":"Incidence of Dravet Syndrome in a US Population","volume":"136","author":"Wu","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.seizure.2024.02.004_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.832380","article-title":"Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes","volume":"13","author":"Ding","year":"2022","journal-title":"Front Neurol."},{"issue":"7","key":"10.1016\/j.seizure.2024.02.004_bib0005","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/jcm12072532","article-title":"Epilepsy in Dravet Syndrome-Current and Future Therapeutic Opportunities","volume":"12","author":"Gao","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.seizure.2024.02.004_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2024.02.004_bib0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10216","key":"10.1016\/j.seizure.2024.02.004_bib0008","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2024.02.004_bib0009","article-title":"Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"issue":"15","key":"10.1016\/j.seizure.2024.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s40265-023-01936-y","article-title":"Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","volume":"83","author":"Lattanzi","year":"2023","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.seizure.2024.02.004_bib0011","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.seizure.2024.02.004_bib0012","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.seizure.2024.02.004_bib0013","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.seizure.2024.02.004_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.seizure.2024.02.004_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Res Synth Methods"},{"issue":"9242","key":"10.1016\/j.seizure.2024.02.004_bib0016","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.seizure.2024.02.004_bib0017","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.seizure.2024.02.004_bib0018","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial","volume":"77","author":"Miller","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.seizure.2024.02.004_bib0019","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/epi.17367","article-title":"A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA)","volume":"63","author":"Hahn","year":"2022","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2024.02.004_bib0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14737175.2019.1593142","article-title":"Stiripentol for the treatment of seizures associated with Dravet syndrome","volume":"19","author":"Chiron","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"36","key":"10.1016\/j.seizure.2024.02.004_bib0021","doi-asserted-by":"crossref","first-page":"14646","DOI":"10.1073\/pnas.1211591109","article-title":"Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome","volume":"109","author":"Cheah","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.seizure.2024.02.004_bib0022","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fphar.2017.00191","article-title":"Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish","volume":"8","author":"Sourbron","year":"2017","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.seizure.2024.02.004_bib0023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40120-023-00452-1","article-title":"Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis","volume":"12","author":"Tabaee Damavandi","year":"2023","journal-title":"Neurol Ther"},{"issue":"7","key":"10.1016\/j.seizure.2024.02.004_bib0024","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2024.02.004_bib0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.seizure.2024.02.004_bib0026","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","article-title":"Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine","volume":"283","author":"Gardin","year":"2000","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.seizure.2024.02.004_bib0027","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1080\/03007995.2017.1355781","article-title":"Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population","volume":"33","author":"Schoonjans","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.seizure.2024.02.004_bib0028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2024.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/epi.16546","article-title":"Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis","volume":"61","author":"Lattanzi","year":"2020","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2024.02.004_bib0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40263-020-00708-6","article-title":"Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety","volume":"34","author":"Lattanzi","year":"2020","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.seizure.2024.02.004_bib0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/14737175.2021.1834383","article-title":"Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome","volume":"21","author":"Lattanzi","year":"2021","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"10.1016\/j.seizure.2024.02.004_bib0032","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/epi.17062","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice","volume":"62","author":"Hawkins","year":"2021","journal-title":"Epilepsia"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T16:28:40Z","timestamp":1744388920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"alternative-id":["S1059131124000323"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.02.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}